In diabetic kidney disease (DKD), Cao et al. [16] reported that Mfn2 regulates the morphology and functions of mitochondria-associated ER membranes (MAMs) and mitochondria by inhibiting the PERK pathway and exerts anti-apoptotic effects on podocytes. This evidence concerns the gene MFN2 and diabetic kidney disease.